Global Neuromodulation Devices and Implantable Infusion Pumps Market Growth 2026-2032
The global Neuromodulation Devices and Implantable Infusion Pumps market size is predicted to grow from US$ 7297 million in 2025 to US$ 11821 million in 2032; it is expected to grow at a CAGR of 7.2% from 2026 to 2032.
Neuromodulation devices and implantable infusion pumps are surgically implanted therapeutic systems that modify neural activity through electrical stimulation or deliver controlled medication directly into the intrathecal space, making them important treatment platforms for chronic pain, movement disorders, epilepsy, sleep-disordered breathing, urinary dysfunction, severe spasticity, and selected refractory neurological conditions.
Upstream supply is concentrated in medical-grade batteries, application-specific integrated circuits, hermetic titanium housings, ceramic or glass feedthroughs, platinum-iridium electrodes, silicone and polyurethane insulation, precision pump mechanisms, catheters, telemetry modules, sterilization services, and validated medical software. Suppliers must maintain long-term material traceability, biocompatibility, hermeticity, electrical safety, cybersecurity, and process-validation capabilities. Downstream buyers are mainly specialist hospitals, neurosurgery centers, pain clinics, epilepsy centers, sleep laboratories, urology departments, rehabilitation centers, and public healthcare systems. Procurement commonly uses annual hospital frameworks, group purchasing agreements, public tenders, distributor contracts, consignment inventories, and case-specific purchasing tied to scheduled implantation procedures.
In the current market, global production is around 252,000 Units, with an average selling price of about 29,600 USD per Unit. The market is highly concentrated because regulatory approvals, multicenter clinical evidence, physician training networks, reimbursement coverage, implant reliability, and long-term patient-support infrastructure are difficult to replicate. The Top 5 suppliers control approximately 76% of global revenue CR5. Medtronic, Boston Scientific, and Abbott operate broad platforms across spinal cord stimulation, deep brain stimulation, sacral neuromodulation, and implantable drug delivery, while Inspire Medical Systems and LivaNova hold strong positions in hypoglossal and vagus nerve stimulation. North America is the principal demand center because of established reimbursement pathways, a large specialist-center network, and comparatively rapid adoption of premium implantable systems. Europe is the second major market, supported by established DBS, SCS, VNS, and infusion-pump use, although national reimbursement conditions vary. China remains smaller in revenue terms but is becoming more important in unit demand as domestic manufacturers expand DBS, SCS, VNS, SNM, and implantable drug-delivery portfolios. The hardware-weighted industry gross margin is estimated at 72.0% in 2025.
During 2026?2032, market development will be shaped by closed-loop stimulation, sensing-enabled implants, adaptive programming, smaller rechargeable devices, extended battery life, remote monitoring, expanded MRI compatibility, and broader indications. AI-assisted programming is expected to improve signal classification, therapy selection, parameter optimization, and clinician workflow, but algorithms incorporated into therapeutic decisions will face stricter validation, cybersecurity, change-control, and post-market surveillance requirements. Replacement demand will remain structurally important because implanted batteries, leads, catheters, and pump mechanisms have finite service lives, although longer-life batteries and rechargeable architectures will lengthen some replacement intervals.
LP Information, Inc. (LPI) ' newest research report, the ?Neuromodulation Devices and Implantable Infusion Pumps Industry Forecast? looks at past sales and reviews total world Neuromodulation Devices and Implantable Infusion Pumps sales in 2025, providing a comprehensive analysis by region and market sector of projected Neuromodulation Devices and Implantable Infusion Pumps sales for 2026 through 2032. With Neuromodulation Devices and Implantable Infusion Pumps sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neuromodulation Devices and Implantable Infusion Pumps industry.
This Insight Report provides a comprehensive analysis of the global Neuromodulation Devices and Implantable Infusion Pumps landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neuromodulation Devices and Implantable Infusion Pumps portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Neuromodulation Devices and Implantable Infusion Pumps market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neuromodulation Devices and Implantable Infusion Pumps and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neuromodulation Devices and Implantable Infusion Pumps.
This report presents a comprehensive overview, market shares, and growth opportunities of Neuromodulation Devices and Implantable Infusion Pumps market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Neuromodulation Devices and Implantable Infusion Pumps market?
What factors are driving Neuromodulation Devices and Implantable Infusion Pumps market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Neuromodulation Devices and Implantable Infusion Pumps market opportunities vary by end market size?
How does Neuromodulation Devices and Implantable Infusion Pumps break out by Type, by Application?
Neuromodulation devices and implantable infusion pumps are surgically implanted therapeutic systems that modify neural activity through electrical stimulation or deliver controlled medication directly into the intrathecal space, making them important treatment platforms for chronic pain, movement disorders, epilepsy, sleep-disordered breathing, urinary dysfunction, severe spasticity, and selected refractory neurological conditions.
Upstream supply is concentrated in medical-grade batteries, application-specific integrated circuits, hermetic titanium housings, ceramic or glass feedthroughs, platinum-iridium electrodes, silicone and polyurethane insulation, precision pump mechanisms, catheters, telemetry modules, sterilization services, and validated medical software. Suppliers must maintain long-term material traceability, biocompatibility, hermeticity, electrical safety, cybersecurity, and process-validation capabilities. Downstream buyers are mainly specialist hospitals, neurosurgery centers, pain clinics, epilepsy centers, sleep laboratories, urology departments, rehabilitation centers, and public healthcare systems. Procurement commonly uses annual hospital frameworks, group purchasing agreements, public tenders, distributor contracts, consignment inventories, and case-specific purchasing tied to scheduled implantation procedures.
In the current market, global production is around 252,000 Units, with an average selling price of about 29,600 USD per Unit. The market is highly concentrated because regulatory approvals, multicenter clinical evidence, physician training networks, reimbursement coverage, implant reliability, and long-term patient-support infrastructure are difficult to replicate. The Top 5 suppliers control approximately 76% of global revenue CR5. Medtronic, Boston Scientific, and Abbott operate broad platforms across spinal cord stimulation, deep brain stimulation, sacral neuromodulation, and implantable drug delivery, while Inspire Medical Systems and LivaNova hold strong positions in hypoglossal and vagus nerve stimulation. North America is the principal demand center because of established reimbursement pathways, a large specialist-center network, and comparatively rapid adoption of premium implantable systems. Europe is the second major market, supported by established DBS, SCS, VNS, and infusion-pump use, although national reimbursement conditions vary. China remains smaller in revenue terms but is becoming more important in unit demand as domestic manufacturers expand DBS, SCS, VNS, SNM, and implantable drug-delivery portfolios. The hardware-weighted industry gross margin is estimated at 72.0% in 2025.
During 2026?2032, market development will be shaped by closed-loop stimulation, sensing-enabled implants, adaptive programming, smaller rechargeable devices, extended battery life, remote monitoring, expanded MRI compatibility, and broader indications. AI-assisted programming is expected to improve signal classification, therapy selection, parameter optimization, and clinician workflow, but algorithms incorporated into therapeutic decisions will face stricter validation, cybersecurity, change-control, and post-market surveillance requirements. Replacement demand will remain structurally important because implanted batteries, leads, catheters, and pump mechanisms have finite service lives, although longer-life batteries and rechargeable architectures will lengthen some replacement intervals.
LP Information, Inc. (LPI) ' newest research report, the ?Neuromodulation Devices and Implantable Infusion Pumps Industry Forecast? looks at past sales and reviews total world Neuromodulation Devices and Implantable Infusion Pumps sales in 2025, providing a comprehensive analysis by region and market sector of projected Neuromodulation Devices and Implantable Infusion Pumps sales for 2026 through 2032. With Neuromodulation Devices and Implantable Infusion Pumps sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neuromodulation Devices and Implantable Infusion Pumps industry.
This Insight Report provides a comprehensive analysis of the global Neuromodulation Devices and Implantable Infusion Pumps landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neuromodulation Devices and Implantable Infusion Pumps portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Neuromodulation Devices and Implantable Infusion Pumps market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neuromodulation Devices and Implantable Infusion Pumps and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neuromodulation Devices and Implantable Infusion Pumps.
This report presents a comprehensive overview, market shares, and growth opportunities of Neuromodulation Devices and Implantable Infusion Pumps market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Neuromodulation Devices
- Implantable Infusion Pumps
- Spinal Cord Stimulation Systems
- Brain Stimulation Systems
- Sacral Neuromodulation Systems
- Cranial Nerve Stimulation Systems
- Peripheral Nerve Stimulation Systems
- Programmable Variable-Rate Pumps
- Constant-Flow Pumps
- Chronic Pain
- Parkinson's Disease
- Sleep-Disordered Breathing
- Urologic Disorders
- Epilepsy
- Spasticity
- Other Therapeutic Applications
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Medtronic
- Boston Scientific
- Abbott
- Inspire Medical Systems
- LivaNova
- Globus Medical
- NeuroPace
- BIOTRONIK
- Saluda Medical
- Mainstay Medical
- Nalu Medical
- Infusyn Therapeutics
- ZOLL Medical
- Beijing PINS Medical
- SceneRay
- Rishena
- Nurotron
- Hangzhou Chengnuo Medical Technology
What is the 10-year outlook for the global Neuromodulation Devices and Implantable Infusion Pumps market?
What factors are driving Neuromodulation Devices and Implantable Infusion Pumps market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Neuromodulation Devices and Implantable Infusion Pumps market opportunities vary by end market size?
How does Neuromodulation Devices and Implantable Infusion Pumps break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Neuromodulation Devices and Implantable Infusion Pumps by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Neuromodulation Devices and Implantable Infusion Pumps by Country/Region, 2021, 2025 & 2032
2.2 Neuromodulation Devices and Implantable Infusion Pumps Segment by Type
2.2.1 Neuromodulation Devices
2.2.2 Implantable Infusion Pumps
2.2.3 Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
2.2.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2021-2026)
2.2.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Type (2021-2026)
2.3 Neuromodulation Devices and Implantable Infusion Pumps Segment by Neuromodulation Device Type
2.3.1 Spinal Cord Stimulation Systems
2.3.2 Brain Stimulation Systems
2.3.3 Sacral Neuromodulation Systems
2.3.4 Cranial Nerve Stimulation Systems
2.3.5 Peripheral Nerve Stimulation Systems
2.3.6 Neuromodulation Devices and Implantable Infusion Pumps Sales by Neuromodulation Device Type
2.3.6.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Neuromodulation Device Type (2021-2026)
2.3.6.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Neuromodulation Device Type (2021-2026)
2.3.6.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Neuromodulation Device Type (2021-2026)
2.4 Neuromodulation Devices and Implantable Infusion Pumps Segment by Implantable Pump Type
2.4.1 Programmable Variable-Rate Pumps
2.4.2 Constant-Flow Pumps
2.4.3 Neuromodulation Devices and Implantable Infusion Pumps Sales by Implantable Pump Type
2.4.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Implantable Pump Type (2021-2026)
2.4.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Implantable Pump Type (2021-2026)
2.4.3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Implantable Pump Type (2021-2026)
2.5 Neuromodulation Devices and Implantable Infusion Pumps Segment by Application
2.5.1 Chronic Pain
2.5.2 Parkinson's Disease
2.5.3 Sleep-Disordered Breathing
2.5.4 Urologic Disorders
2.5.5 Epilepsy
2.5.6 Spasticity
2.5.7 Other Therapeutic Applications
2.5.8 Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
2.5.8.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Market Share by Application (2021-2026)
2.5.8.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Application (2021-2026)
2.5.8.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Breakdown Data by Company
3.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Sales by Company (2021-2026)
3.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2021-2026)
3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue by Company (2021-2026)
3.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2021-2026)
3.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company (2021-2026)
3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Company
3.4 Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Product Location Distribution
3.4.2 Players Neuromodulation Devices and Implantable Infusion Pumps Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NEUROMODULATION DEVICES AND IMPLANTABLE INFUSION PUMPS BY GEOGRAPHIC REGION
4.1 World Historic Neuromodulation Devices and Implantable Infusion Pumps Market Size by Geographic Region (2021-2026)
4.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country/Region (2021-2026)
4.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Sales by Country/Region (2021-2026)
4.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue by Country/Region (2021-2026)
4.3 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Growth
4.4 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Growth
4.5 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Growth
4.6 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Growth
5 AMERICAS
5.1 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
5.1.1 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026)
5.1.2 Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2021-2026)
5.2 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026)
5.3 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Region
6.1.1 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2021-2026)
6.1.2 APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2021-2026)
6.2 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026)
6.3 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Neuromodulation Devices and Implantable Infusion Pumps by Country
7.1.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026)
7.1.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2021-2026)
7.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026)
7.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps by Country
8.1.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026)
8.1.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2021-2026)
8.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026)
8.3 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neuromodulation Devices and Implantable Infusion Pumps
10.3 Manufacturing Process Analysis of Neuromodulation Devices and Implantable Infusion Pumps
10.4 Industry Chain Structure of Neuromodulation Devices and Implantable Infusion Pumps
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neuromodulation Devices and Implantable Infusion Pumps Distributors
11.3 Neuromodulation Devices and Implantable Infusion Pumps Customer
12 WORLD FORECAST REVIEW FOR NEUROMODULATION DEVICES AND IMPLANTABLE INFUSION PUMPS BY GEOGRAPHIC REGION
12.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Region
12.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Region (2027-2032)
12.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Type (2027-2032)
12.7 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Boston Scientific
13.2.1 Boston Scientific Company Information
13.2.2 Boston Scientific Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.2.3 Boston Scientific Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Boston Scientific Main Business Overview
13.2.5 Boston Scientific Latest Developments
13.3 Abbott
13.3.1 Abbott Company Information
13.3.2 Abbott Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.3.3 Abbott Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Abbott Main Business Overview
13.3.5 Abbott Latest Developments
13.4 Inspire Medical Systems
13.4.1 Inspire Medical Systems Company Information
13.4.2 Inspire Medical Systems Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.4.3 Inspire Medical Systems Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Inspire Medical Systems Main Business Overview
13.4.5 Inspire Medical Systems Latest Developments
13.5 LivaNova
13.5.1 LivaNova Company Information
13.5.2 LivaNova Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.5.3 LivaNova Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 LivaNova Main Business Overview
13.5.5 LivaNova Latest Developments
13.6 Globus Medical
13.6.1 Globus Medical Company Information
13.6.2 Globus Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.6.3 Globus Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Globus Medical Main Business Overview
13.6.5 Globus Medical Latest Developments
13.7 NeuroPace
13.7.1 NeuroPace Company Information
13.7.2 NeuroPace Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.7.3 NeuroPace Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 NeuroPace Main Business Overview
13.7.5 NeuroPace Latest Developments
13.8 BIOTRONIK
13.8.1 BIOTRONIK Company Information
13.8.2 BIOTRONIK Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.8.3 BIOTRONIK Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 BIOTRONIK Main Business Overview
13.8.5 BIOTRONIK Latest Developments
13.9 Saluda Medical
13.9.1 Saluda Medical Company Information
13.9.2 Saluda Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.9.3 Saluda Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Saluda Medical Main Business Overview
13.9.5 Saluda Medical Latest Developments
13.10 Mainstay Medical
13.10.1 Mainstay Medical Company Information
13.10.2 Mainstay Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.10.3 Mainstay Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Mainstay Medical Main Business Overview
13.10.5 Mainstay Medical Latest Developments
13.11 Nalu Medical
13.11.1 Nalu Medical Company Information
13.11.2 Nalu Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.11.3 Nalu Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Nalu Medical Main Business Overview
13.11.5 Nalu Medical Latest Developments
13.12 Infusyn Therapeutics
13.12.1 Infusyn Therapeutics Company Information
13.12.2 Infusyn Therapeutics Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.12.3 Infusyn Therapeutics Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Infusyn Therapeutics Main Business Overview
13.12.5 Infusyn Therapeutics Latest Developments
13.13 ZOLL Medical
13.13.1 ZOLL Medical Company Information
13.13.2 ZOLL Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.13.3 ZOLL Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 ZOLL Medical Main Business Overview
13.13.5 ZOLL Medical Latest Developments
13.14 Beijing PINS Medical
13.14.1 Beijing PINS Medical Company Information
13.14.2 Beijing PINS Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.14.3 Beijing PINS Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Beijing PINS Medical Main Business Overview
13.14.5 Beijing PINS Medical Latest Developments
13.15 SceneRay
13.15.1 SceneRay Company Information
13.15.2 SceneRay Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.15.3 SceneRay Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 SceneRay Main Business Overview
13.15.5 SceneRay Latest Developments
13.16 Rishena
13.16.1 Rishena Company Information
13.16.2 Rishena Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.16.3 Rishena Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Rishena Main Business Overview
13.16.5 Rishena Latest Developments
13.17 Nurotron
13.17.1 Nurotron Company Information
13.17.2 Nurotron Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.17.3 Nurotron Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Nurotron Main Business Overview
13.17.5 Nurotron Latest Developments
13.18 Hangzhou Chengnuo Medical Technology
13.18.1 Hangzhou Chengnuo Medical Technology Company Information
13.18.2 Hangzhou Chengnuo Medical Technology Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.18.3 Hangzhou Chengnuo Medical Technology Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Hangzhou Chengnuo Medical Technology Main Business Overview
13.18.5 Hangzhou Chengnuo Medical Technology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Neuromodulation Devices and Implantable Infusion Pumps by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Neuromodulation Devices and Implantable Infusion Pumps by Country/Region, 2021, 2025 & 2032
2.2 Neuromodulation Devices and Implantable Infusion Pumps Segment by Type
2.2.1 Neuromodulation Devices
2.2.2 Implantable Infusion Pumps
2.2.3 Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
2.2.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2021-2026)
2.2.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Type (2021-2026)
2.3 Neuromodulation Devices and Implantable Infusion Pumps Segment by Neuromodulation Device Type
2.3.1 Spinal Cord Stimulation Systems
2.3.2 Brain Stimulation Systems
2.3.3 Sacral Neuromodulation Systems
2.3.4 Cranial Nerve Stimulation Systems
2.3.5 Peripheral Nerve Stimulation Systems
2.3.6 Neuromodulation Devices and Implantable Infusion Pumps Sales by Neuromodulation Device Type
2.3.6.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Neuromodulation Device Type (2021-2026)
2.3.6.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Neuromodulation Device Type (2021-2026)
2.3.6.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Neuromodulation Device Type (2021-2026)
2.4 Neuromodulation Devices and Implantable Infusion Pumps Segment by Implantable Pump Type
2.4.1 Programmable Variable-Rate Pumps
2.4.2 Constant-Flow Pumps
2.4.3 Neuromodulation Devices and Implantable Infusion Pumps Sales by Implantable Pump Type
2.4.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Implantable Pump Type (2021-2026)
2.4.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Implantable Pump Type (2021-2026)
2.4.3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Implantable Pump Type (2021-2026)
2.5 Neuromodulation Devices and Implantable Infusion Pumps Segment by Application
2.5.1 Chronic Pain
2.5.2 Parkinson's Disease
2.5.3 Sleep-Disordered Breathing
2.5.4 Urologic Disorders
2.5.5 Epilepsy
2.5.6 Spasticity
2.5.7 Other Therapeutic Applications
2.5.8 Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
2.5.8.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Market Share by Application (2021-2026)
2.5.8.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Application (2021-2026)
2.5.8.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Breakdown Data by Company
3.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Sales by Company (2021-2026)
3.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2021-2026)
3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue by Company (2021-2026)
3.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2021-2026)
3.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company (2021-2026)
3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Company
3.4 Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Product Location Distribution
3.4.2 Players Neuromodulation Devices and Implantable Infusion Pumps Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NEUROMODULATION DEVICES AND IMPLANTABLE INFUSION PUMPS BY GEOGRAPHIC REGION
4.1 World Historic Neuromodulation Devices and Implantable Infusion Pumps Market Size by Geographic Region (2021-2026)
4.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country/Region (2021-2026)
4.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Sales by Country/Region (2021-2026)
4.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue by Country/Region (2021-2026)
4.3 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Growth
4.4 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Growth
4.5 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Growth
4.6 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Growth
5 AMERICAS
5.1 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
5.1.1 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026)
5.1.2 Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2021-2026)
5.2 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026)
5.3 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Region
6.1.1 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2021-2026)
6.1.2 APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2021-2026)
6.2 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026)
6.3 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Neuromodulation Devices and Implantable Infusion Pumps by Country
7.1.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026)
7.1.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2021-2026)
7.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026)
7.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps by Country
8.1.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026)
8.1.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2021-2026)
8.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026)
8.3 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neuromodulation Devices and Implantable Infusion Pumps
10.3 Manufacturing Process Analysis of Neuromodulation Devices and Implantable Infusion Pumps
10.4 Industry Chain Structure of Neuromodulation Devices and Implantable Infusion Pumps
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neuromodulation Devices and Implantable Infusion Pumps Distributors
11.3 Neuromodulation Devices and Implantable Infusion Pumps Customer
12 WORLD FORECAST REVIEW FOR NEUROMODULATION DEVICES AND IMPLANTABLE INFUSION PUMPS BY GEOGRAPHIC REGION
12.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Region
12.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Region (2027-2032)
12.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Type (2027-2032)
12.7 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Boston Scientific
13.2.1 Boston Scientific Company Information
13.2.2 Boston Scientific Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.2.3 Boston Scientific Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Boston Scientific Main Business Overview
13.2.5 Boston Scientific Latest Developments
13.3 Abbott
13.3.1 Abbott Company Information
13.3.2 Abbott Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.3.3 Abbott Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Abbott Main Business Overview
13.3.5 Abbott Latest Developments
13.4 Inspire Medical Systems
13.4.1 Inspire Medical Systems Company Information
13.4.2 Inspire Medical Systems Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.4.3 Inspire Medical Systems Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Inspire Medical Systems Main Business Overview
13.4.5 Inspire Medical Systems Latest Developments
13.5 LivaNova
13.5.1 LivaNova Company Information
13.5.2 LivaNova Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.5.3 LivaNova Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 LivaNova Main Business Overview
13.5.5 LivaNova Latest Developments
13.6 Globus Medical
13.6.1 Globus Medical Company Information
13.6.2 Globus Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.6.3 Globus Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Globus Medical Main Business Overview
13.6.5 Globus Medical Latest Developments
13.7 NeuroPace
13.7.1 NeuroPace Company Information
13.7.2 NeuroPace Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.7.3 NeuroPace Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 NeuroPace Main Business Overview
13.7.5 NeuroPace Latest Developments
13.8 BIOTRONIK
13.8.1 BIOTRONIK Company Information
13.8.2 BIOTRONIK Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.8.3 BIOTRONIK Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 BIOTRONIK Main Business Overview
13.8.5 BIOTRONIK Latest Developments
13.9 Saluda Medical
13.9.1 Saluda Medical Company Information
13.9.2 Saluda Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.9.3 Saluda Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Saluda Medical Main Business Overview
13.9.5 Saluda Medical Latest Developments
13.10 Mainstay Medical
13.10.1 Mainstay Medical Company Information
13.10.2 Mainstay Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.10.3 Mainstay Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Mainstay Medical Main Business Overview
13.10.5 Mainstay Medical Latest Developments
13.11 Nalu Medical
13.11.1 Nalu Medical Company Information
13.11.2 Nalu Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.11.3 Nalu Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Nalu Medical Main Business Overview
13.11.5 Nalu Medical Latest Developments
13.12 Infusyn Therapeutics
13.12.1 Infusyn Therapeutics Company Information
13.12.2 Infusyn Therapeutics Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.12.3 Infusyn Therapeutics Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Infusyn Therapeutics Main Business Overview
13.12.5 Infusyn Therapeutics Latest Developments
13.13 ZOLL Medical
13.13.1 ZOLL Medical Company Information
13.13.2 ZOLL Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.13.3 ZOLL Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 ZOLL Medical Main Business Overview
13.13.5 ZOLL Medical Latest Developments
13.14 Beijing PINS Medical
13.14.1 Beijing PINS Medical Company Information
13.14.2 Beijing PINS Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.14.3 Beijing PINS Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Beijing PINS Medical Main Business Overview
13.14.5 Beijing PINS Medical Latest Developments
13.15 SceneRay
13.15.1 SceneRay Company Information
13.15.2 SceneRay Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.15.3 SceneRay Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 SceneRay Main Business Overview
13.15.5 SceneRay Latest Developments
13.16 Rishena
13.16.1 Rishena Company Information
13.16.2 Rishena Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.16.3 Rishena Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Rishena Main Business Overview
13.16.5 Rishena Latest Developments
13.17 Nurotron
13.17.1 Nurotron Company Information
13.17.2 Nurotron Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.17.3 Nurotron Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Nurotron Main Business Overview
13.17.5 Nurotron Latest Developments
13.18 Hangzhou Chengnuo Medical Technology
13.18.1 Hangzhou Chengnuo Medical Technology Company Information
13.18.2 Hangzhou Chengnuo Medical Technology Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.18.3 Hangzhou Chengnuo Medical Technology Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Hangzhou Chengnuo Medical Technology Main Business Overview
13.18.5 Hangzhou Chengnuo Medical Technology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Neuromodulation Devices and Implantable Infusion Pumps Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Neuromodulation Devices and Implantable Infusion Pumps Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Neuromodulation Devices
Table 4. Major Players of Implantable Infusion Pumps
Table 5. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (Unit)
Table 6. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2021-2026)
Table 7. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2021-2026) & ($ million)
Table 8. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2021-2026)
Table 9. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Type (2021-2026) & (USD/Unit)
Table 10. Major Players of Spinal Cord Stimulation Systems
Table 11. Major Players of Brain Stimulation Systems
Table 12. Major Players of Sacral Neuromodulation Systems
Table 13. Major Players of Cranial Nerve Stimulation Systems
Table 14. Major Players of Peripheral Nerve Stimulation Systems
Table 15. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Neuromodulation Device Type (2021-2026) & (Unit)
Table 16. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Neuromodulation Device Type (2021-2026)
Table 17. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Neuromodulation Device Type (2021-2026) & ($ million)
Table 18. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Neuromodulation Device Type (2021-2026)
Table 19. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Neuromodulation Device Type (2021-2026) & (USD/Unit)
Table 20. Major Players of Programmable Variable-Rate Pumps
Table 21. Major Players of Constant-Flow Pumps
Table 22. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Implantable Pump Type (2021-2026) & (Unit)
Table 23. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Implantable Pump Type (2021-2026)
Table 24. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Implantable Pump Type (2021-2026) & ($ million)
Table 25. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Implantable Pump Type (2021-2026)
Table 26. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Implantable Pump Type (2021-2026) & (USD/Unit)
Table 27. Global Neuromodulation Devices and Implantable Infusion Pumps Sale by Application (2021-2026) & (Unit)
Table 28. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Market Share by Application (2021-2026)
Table 29. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2021-2026) & ($ million)
Table 30. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2021-2026)
Table 31. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Application (2021-2026) & (USD/Unit)
Table 32. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Company (2021-2026) & (Unit)
Table 33. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2021-2026)
Table 34. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2021-2026) & ($ millions)
Table 35. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company (2021-2026)
Table 36. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Company (2021-2026) & (USD/Unit)
Table 37. Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Producing Area Distribution and Sales Area
Table 38. Players Neuromodulation Devices and Implantable Infusion Pumps Products Offered
Table 39. Neuromodulation Devices and Implantable Infusion Pumps Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Geographic Region (2021-2026) & (Unit)
Table 43. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Geographic Region (2021-2026)
Table 44. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Country/Region (2021-2026) & (Unit)
Table 47. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country/Region (2021-2026)
Table 48. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026) & (Unit)
Table 51. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2021-2026)
Table 52. Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (Unit)
Table 54. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (Unit)
Table 55. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2021-2026) & (Unit)
Table 56. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2021-2026)
Table 57. APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (Unit)
Table 59. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (Unit)
Table 60. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026) & (Unit)
Table 61. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (Unit)
Table 63. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (Unit)
Table 64. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026) & (Unit)
Table 65. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (Unit)
Table 67. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (Unit)
Table 68. Key Market Drivers & Growth Opportunities of Neuromodulation Devices and Implantable Infusion Pumps
Table 69. Key Market Challenges & Risks of Neuromodulation Devices and Implantable Infusion Pumps
Table 70. Key Industry Trends of Neuromodulation Devices and Implantable Infusion Pumps
Table 71. Neuromodulation Devices and Implantable Infusion Pumps Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Neuromodulation Devices and Implantable Infusion Pumps Distributors List
Table 74. Neuromodulation Devices and Implantable Infusion Pumps Customer List
Table 75. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Region (2027-2032) & (Unit)
Table 76. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2027-2032) & (Unit)
Table 78. Americas Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Region (2027-2032) & (Unit)
Table 80. APAC Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2027-2032) & (Unit)
Table 82. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2027-2032) & (Unit)
Table 84. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Type (2027-2032) & (Unit)
Table 86. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Type (2027-2032) & ($ millions)
Table 87. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Application (2027-2032) & (Unit)
Table 88. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. Medtronic Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 90. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 91. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 92. Medtronic Main Business
Table 93. Medtronic Latest Developments
Table 94. Boston Scientific Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 95. Boston Scientific Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 96. Boston Scientific Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 97. Boston Scientific Main Business
Table 98. Boston Scientific Latest Developments
Table 99. Abbott Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 100. Abbott Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 101. Abbott Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 102. Abbott Main Business
Table 103. Abbott Latest Developments
Table 104. Inspire Medical Systems Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 105. Inspire Medical Systems Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 106. Inspire Medical Systems Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 107. Inspire Medical Systems Main Business
Table 108. Inspire Medical Systems Latest Developments
Table 109. LivaNova Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 110. LivaNova Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 111. LivaNova Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 112. LivaNova Main Business
Table 113. LivaNova Latest Developments
Table 114. Globus Medical Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 115. Globus Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 116. Globus Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 117. Globus Medical Main Business
Table 118. Globus Medical Latest Developments
Table 119. NeuroPace Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 120. NeuroPace Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 121. NeuroPace Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 122. NeuroPace Main Business
Table 123. NeuroPace Latest Developments
Table 124. BIOTRONIK Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 125. BIOTRONIK Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 126. BIOTRONIK Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 127. BIOTRONIK Main Business
Table 128. BIOTRONIK Latest Developments
Table 129. Saluda Medical Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 130. Saluda Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 131. Saluda Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 132. Saluda Medical Main Business
Table 133. Saluda Medical Latest Developments
Table 134. Mainstay Medical Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 135. Mainstay Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 136. Mainstay Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 137. Mainstay Medical Main Business
Table 138. Mainstay Medical Latest Developments
Table 139. Nalu Medical Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 140. Nalu Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 141. Nalu Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 142. Nalu Medical Main Business
Table 143. Nalu Medical Latest Developments
Table 144. Infusyn Therapeutics Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 145. Infusyn Therapeutics Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 146. Infusyn Therapeutics Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 147. Infusyn Therapeutics Main Business
Table 148. Infusyn Therapeutics Latest Developments
Table 149. ZOLL Medical Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 150. ZOLL Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 151. ZOLL Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 152. ZOLL Medical Main Business
Table 153. ZOLL Medical Latest Developments
Table 154. Beijing PINS Medical Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 155. Beijing PINS Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 156. Beijing PINS Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 157. Beijing PINS Medical Main Business
Table 158. Beijing PINS Medical Latest Developments
Table 159. SceneRay Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 160. SceneRay Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 161. SceneRay Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 162. SceneRay Main Business
Table 163. SceneRay Latest Developments
Table 164. Rishena Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 165. Rishena Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 166. Rishena Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 167. Rishena Main Business
Table 168. Rishena Latest Developments
Table 169. Nurotron Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 170. Nurotron Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 171. Nurotron Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 172. Nurotron Main Business
Table 173. Nurotron Latest Developments
Table 174. Hangzhou Chengnuo Medical Technology Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 175. Hangzhou Chengnuo Medical Technology Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 176. Hangzhou Chengnuo Medical Technology Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 177. Hangzhou Chengnuo Medical Technology Main Business
Table 178. Hangzhou Chengnuo Medical Technology Latest Developments
Table 1. Neuromodulation Devices and Implantable Infusion Pumps Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Neuromodulation Devices and Implantable Infusion Pumps Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Neuromodulation Devices
Table 4. Major Players of Implantable Infusion Pumps
Table 5. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (Unit)
Table 6. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2021-2026)
Table 7. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2021-2026) & ($ million)
Table 8. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2021-2026)
Table 9. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Type (2021-2026) & (USD/Unit)
Table 10. Major Players of Spinal Cord Stimulation Systems
Table 11. Major Players of Brain Stimulation Systems
Table 12. Major Players of Sacral Neuromodulation Systems
Table 13. Major Players of Cranial Nerve Stimulation Systems
Table 14. Major Players of Peripheral Nerve Stimulation Systems
Table 15. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Neuromodulation Device Type (2021-2026) & (Unit)
Table 16. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Neuromodulation Device Type (2021-2026)
Table 17. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Neuromodulation Device Type (2021-2026) & ($ million)
Table 18. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Neuromodulation Device Type (2021-2026)
Table 19. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Neuromodulation Device Type (2021-2026) & (USD/Unit)
Table 20. Major Players of Programmable Variable-Rate Pumps
Table 21. Major Players of Constant-Flow Pumps
Table 22. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Implantable Pump Type (2021-2026) & (Unit)
Table 23. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Implantable Pump Type (2021-2026)
Table 24. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Implantable Pump Type (2021-2026) & ($ million)
Table 25. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Implantable Pump Type (2021-2026)
Table 26. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Implantable Pump Type (2021-2026) & (USD/Unit)
Table 27. Global Neuromodulation Devices and Implantable Infusion Pumps Sale by Application (2021-2026) & (Unit)
Table 28. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Market Share by Application (2021-2026)
Table 29. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2021-2026) & ($ million)
Table 30. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2021-2026)
Table 31. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Application (2021-2026) & (USD/Unit)
Table 32. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Company (2021-2026) & (Unit)
Table 33. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2021-2026)
Table 34. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2021-2026) & ($ millions)
Table 35. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company (2021-2026)
Table 36. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Company (2021-2026) & (USD/Unit)
Table 37. Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Producing Area Distribution and Sales Area
Table 38. Players Neuromodulation Devices and Implantable Infusion Pumps Products Offered
Table 39. Neuromodulation Devices and Implantable Infusion Pumps Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Geographic Region (2021-2026) & (Unit)
Table 43. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Geographic Region (2021-2026)
Table 44. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Country/Region (2021-2026) & (Unit)
Table 47. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country/Region (2021-2026)
Table 48. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026) & (Unit)
Table 51. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2021-2026)
Table 52. Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (Unit)
Table 54. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (Unit)
Table 55. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2021-2026) & (Unit)
Table 56. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2021-2026)
Table 57. APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (Unit)
Table 59. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (Unit)
Table 60. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026) & (Unit)
Table 61. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (Unit)
Table 63. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (Unit)
Table 64. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026) & (Unit)
Table 65. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (Unit)
Table 67. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (Unit)
Table 68. Key Market Drivers & Growth Opportunities of Neuromodulation Devices and Implantable Infusion Pumps
Table 69. Key Market Challenges & Risks of Neuromodulation Devices and Implantable Infusion Pumps
Table 70. Key Industry Trends of Neuromodulation Devices and Implantable Infusion Pumps
Table 71. Neuromodulation Devices and Implantable Infusion Pumps Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Neuromodulation Devices and Implantable Infusion Pumps Distributors List
Table 74. Neuromodulation Devices and Implantable Infusion Pumps Customer List
Table 75. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Region (2027-2032) & (Unit)
Table 76. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2027-2032) & (Unit)
Table 78. Americas Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Region (2027-2032) & (Unit)
Table 80. APAC Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2027-2032) & (Unit)
Table 82. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2027-2032) & (Unit)
Table 84. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Type (2027-2032) & (Unit)
Table 86. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Type (2027-2032) & ($ millions)
Table 87. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Application (2027-2032) & (Unit)
Table 88. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. Medtronic Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 90. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 91. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 92. Medtronic Main Business
Table 93. Medtronic Latest Developments
Table 94. Boston Scientific Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 95. Boston Scientific Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 96. Boston Scientific Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 97. Boston Scientific Main Business
Table 98. Boston Scientific Latest Developments
Table 99. Abbott Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 100. Abbott Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 101. Abbott Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 102. Abbott Main Business
Table 103. Abbott Latest Developments
Table 104. Inspire Medical Systems Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 105. Inspire Medical Systems Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 106. Inspire Medical Systems Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 107. Inspire Medical Systems Main Business
Table 108. Inspire Medical Systems Latest Developments
Table 109. LivaNova Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 110. LivaNova Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 111. LivaNova Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 112. LivaNova Main Business
Table 113. LivaNova Latest Developments
Table 114. Globus Medical Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 115. Globus Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 116. Globus Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 117. Globus Medical Main Business
Table 118. Globus Medical Latest Developments
Table 119. NeuroPace Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 120. NeuroPace Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 121. NeuroPace Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 122. NeuroPace Main Business
Table 123. NeuroPace Latest Developments
Table 124. BIOTRONIK Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 125. BIOTRONIK Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 126. BIOTRONIK Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 127. BIOTRONIK Main Business
Table 128. BIOTRONIK Latest Developments
Table 129. Saluda Medical Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 130. Saluda Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 131. Saluda Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 132. Saluda Medical Main Business
Table 133. Saluda Medical Latest Developments
Table 134. Mainstay Medical Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 135. Mainstay Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 136. Mainstay Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 137. Mainstay Medical Main Business
Table 138. Mainstay Medical Latest Developments
Table 139. Nalu Medical Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 140. Nalu Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 141. Nalu Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 142. Nalu Medical Main Business
Table 143. Nalu Medical Latest Developments
Table 144. Infusyn Therapeutics Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 145. Infusyn Therapeutics Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 146. Infusyn Therapeutics Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 147. Infusyn Therapeutics Main Business
Table 148. Infusyn Therapeutics Latest Developments
Table 149. ZOLL Medical Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 150. ZOLL Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 151. ZOLL Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 152. ZOLL Medical Main Business
Table 153. ZOLL Medical Latest Developments
Table 154. Beijing PINS Medical Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 155. Beijing PINS Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 156. Beijing PINS Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 157. Beijing PINS Medical Main Business
Table 158. Beijing PINS Medical Latest Developments
Table 159. SceneRay Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 160. SceneRay Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 161. SceneRay Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 162. SceneRay Main Business
Table 163. SceneRay Latest Developments
Table 164. Rishena Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 165. Rishena Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 166. Rishena Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 167. Rishena Main Business
Table 168. Rishena Latest Developments
Table 169. Nurotron Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 170. Nurotron Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 171. Nurotron Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 172. Nurotron Main Business
Table 173. Nurotron Latest Developments
Table 174. Hangzhou Chengnuo Medical Technology Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 175. Hangzhou Chengnuo Medical Technology Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 176. Hangzhou Chengnuo Medical Technology Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 177. Hangzhou Chengnuo Medical Technology Main Business
Table 178. Hangzhou Chengnuo Medical Technology Latest Developments
LIST OF FIGURES
Figure 1. Picture of Neuromodulation Devices and Implantable Infusion Pumps
Figure 2. Neuromodulation Devices and Implantable Infusion Pumps Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate 2021-2032 (Unit)
Figure 7. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Neuromodulation Devices and Implantable Infusion Pumps Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country/Region (2025)
Figure 10. Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Neuromodulation Devices
Figure 12. Product Picture of Implantable Infusion Pumps
Figure 13. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type in 2026
Figure 14. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Spinal Cord Stimulation Systems
Figure 16. Product Picture of Brain Stimulation Systems
Figure 17. Product Picture of Sacral Neuromodulation Systems
Figure 18. Product Picture of Cranial Nerve Stimulation Systems
Figure 19. Product Picture of Peripheral Nerve Stimulation Systems
Figure 20. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Neuromodulation Device Type in 2026
Figure 21. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Neuromodulation Device Type (2021-2026)
Figure 22. Product Picture of Programmable Variable-Rate Pumps
Figure 23. Product Picture of Constant-Flow Pumps
Figure 24. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Implantable Pump Type in 2026
Figure 25. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Implantable Pump Type (2021-2026)
Figure 26. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Chronic Pain
Figure 27. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Chronic Pain (2021-2026) & (Unit)
Figure 28. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Parkinson's Disease
Figure 29. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Parkinson's Disease (2021-2026) & (Unit)
Figure 30. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Sleep-Disordered Breathing
Figure 31. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Sleep-Disordered Breathing (2021-2026) & (Unit)
Figure 32. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Urologic Disorders
Figure 33. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Urologic Disorders (2021-2026) & (Unit)
Figure 34. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Epilepsy
Figure 35. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Epilepsy (2021-2026) & (Unit)
Figure 36. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Spasticity
Figure 37. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Spasticity (2021-2026) & (Unit)
Figure 38. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Other Therapeutic Applications
Figure 39. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Other Therapeutic Applications (2021-2026) & (Unit)
Figure 40. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Market Share by Application (2025)
Figure 41. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application in 2025
Figure 42. Neuromodulation Devices and Implantable Infusion Pumps Sales by Company in 2025 (Unit)
Figure 43. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company in 2025
Figure 44. Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company in 2025 ($ millions)
Figure 45. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company in 2025
Figure 46. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Geographic Region (2021-2026)
Figure 47. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Geographic Region in 2025
Figure 48. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales 2021-2026 (Unit)
Figure 49. Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue 2021-2026 ($ millions)
Figure 50. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales 2021-2026 (Unit)
Figure 51. APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue 2021-2026 ($ millions)
Figure 52. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales 2021-2026 (Unit)
Figure 53. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue 2021-2026 ($ millions)
Figure 54. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales 2021-2026 (Unit)
Figure 55. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue 2021-2026 ($ millions)
Figure 56. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country in 2025
Figure 57. Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2021-2026)
Figure 58. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2021-2026)
Figure 59. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2021-2026)
Figure 60. United States Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 61. Canada Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 62. Mexico Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 63. Brazil Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 64. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region in 2025
Figure 65. APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2021-2026)
Figure 66. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2021-2026)
Figure 67. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2021-2026)
Figure 68. China Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 69. Japan Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 70. South Korea Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 71. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 72. India Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 73. Australia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 74. China Taiwan Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 75. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country in 2025
Figure 76. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2021-2026)
Figure 77. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2021-2026)
Figure 78. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2021-2026)
Figure 79. Germany Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 80. France Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 81. UK Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 82. Italy Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 83. Russia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 84. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2021-2026)
Figure 85. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2021-2026)
Figure 86. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2021-2026)
Figure 87. Egypt Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 88. South Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 89. Israel Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 90. Turkey Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 91. GCC Countries Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 92. Manufacturing Cost Structure Analysis of Neuromodulation Devices and Implantable Infusion Pumps in 2026
Figure 93. Manufacturing Process Analysis of Neuromodulation Devices and Implantable Infusion Pumps
Figure 94. Industry Chain Structure of Neuromodulation Devices and Implantable Infusion Pumps
Figure 95. Channels of Distribution
Figure 96. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Forecast by Region (2027-2032)
Figure 97. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share Forecast by Region (2027-2032)
Figure 98. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Forecast by Type (2027-2032)
Figure 99. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share Forecast by Type (2027-2032)
Figure 100. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Forecast by Application (2027-2032)
Figure 101. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Neuromodulation Devices and Implantable Infusion Pumps
Figure 2. Neuromodulation Devices and Implantable Infusion Pumps Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate 2021-2032 (Unit)
Figure 7. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Neuromodulation Devices and Implantable Infusion Pumps Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country/Region (2025)
Figure 10. Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Neuromodulation Devices
Figure 12. Product Picture of Implantable Infusion Pumps
Figure 13. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type in 2026
Figure 14. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Spinal Cord Stimulation Systems
Figure 16. Product Picture of Brain Stimulation Systems
Figure 17. Product Picture of Sacral Neuromodulation Systems
Figure 18. Product Picture of Cranial Nerve Stimulation Systems
Figure 19. Product Picture of Peripheral Nerve Stimulation Systems
Figure 20. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Neuromodulation Device Type in 2026
Figure 21. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Neuromodulation Device Type (2021-2026)
Figure 22. Product Picture of Programmable Variable-Rate Pumps
Figure 23. Product Picture of Constant-Flow Pumps
Figure 24. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Implantable Pump Type in 2026
Figure 25. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Implantable Pump Type (2021-2026)
Figure 26. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Chronic Pain
Figure 27. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Chronic Pain (2021-2026) & (Unit)
Figure 28. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Parkinson's Disease
Figure 29. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Parkinson's Disease (2021-2026) & (Unit)
Figure 30. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Sleep-Disordered Breathing
Figure 31. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Sleep-Disordered Breathing (2021-2026) & (Unit)
Figure 32. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Urologic Disorders
Figure 33. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Urologic Disorders (2021-2026) & (Unit)
Figure 34. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Epilepsy
Figure 35. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Epilepsy (2021-2026) & (Unit)
Figure 36. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Spasticity
Figure 37. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Spasticity (2021-2026) & (Unit)
Figure 38. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Other Therapeutic Applications
Figure 39. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Other Therapeutic Applications (2021-2026) & (Unit)
Figure 40. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Market Share by Application (2025)
Figure 41. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application in 2025
Figure 42. Neuromodulation Devices and Implantable Infusion Pumps Sales by Company in 2025 (Unit)
Figure 43. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company in 2025
Figure 44. Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company in 2025 ($ millions)
Figure 45. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company in 2025
Figure 46. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Geographic Region (2021-2026)
Figure 47. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Geographic Region in 2025
Figure 48. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales 2021-2026 (Unit)
Figure 49. Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue 2021-2026 ($ millions)
Figure 50. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales 2021-2026 (Unit)
Figure 51. APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue 2021-2026 ($ millions)
Figure 52. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales 2021-2026 (Unit)
Figure 53. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue 2021-2026 ($ millions)
Figure 54. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales 2021-2026 (Unit)
Figure 55. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue 2021-2026 ($ millions)
Figure 56. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country in 2025
Figure 57. Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2021-2026)
Figure 58. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2021-2026)
Figure 59. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2021-2026)
Figure 60. United States Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 61. Canada Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 62. Mexico Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 63. Brazil Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 64. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region in 2025
Figure 65. APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2021-2026)
Figure 66. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2021-2026)
Figure 67. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2021-2026)
Figure 68. China Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 69. Japan Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 70. South Korea Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 71. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 72. India Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 73. Australia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 74. China Taiwan Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 75. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country in 2025
Figure 76. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2021-2026)
Figure 77. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2021-2026)
Figure 78. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2021-2026)
Figure 79. Germany Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 80. France Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 81. UK Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 82. Italy Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 83. Russia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 84. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2021-2026)
Figure 85. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2021-2026)
Figure 86. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2021-2026)
Figure 87. Egypt Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 88. South Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 89. Israel Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 90. Turkey Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 91. GCC Countries Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 92. Manufacturing Cost Structure Analysis of Neuromodulation Devices and Implantable Infusion Pumps in 2026
Figure 93. Manufacturing Process Analysis of Neuromodulation Devices and Implantable Infusion Pumps
Figure 94. Industry Chain Structure of Neuromodulation Devices and Implantable Infusion Pumps
Figure 95. Channels of Distribution
Figure 96. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Forecast by Region (2027-2032)
Figure 97. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share Forecast by Region (2027-2032)
Figure 98. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Forecast by Type (2027-2032)
Figure 99. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share Forecast by Type (2027-2032)
Figure 100. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Forecast by Application (2027-2032)
Figure 101. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share Forecast by Application (2027-2032)
